Radiation therapy's contribution to local control and progression-free survival in patients with aggressive lymphomas.

被引：0
|
作者：
Wilder, RB [1 ]
Rodriguez, MA [1 ]
Tucker, SL [1 ]
Ha, CS [1 ]
Hess, MA [1 ]
Cabanillas, FF [1 ]
Cox, JD [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4814
引用
收藏
页码：251B / 251B
页数：1
相关论文
共 50 条
  • [31] Complex Karyotype Is Associated With Aggressive Disease and Shortened Progression-Free Survival in Patients With Newly Diagnosed Mantle Cell Lymphoma
    Cohen, Jonathon B.
    Ruppert, Amy S.
    Heerema, Nyla A.
    Andritsos, Leslie A.
    Jones, Jeffrey A.
    Porcu, Pierluigi
    Baiocchi, Robert
    Christian, Beth A.
    Byrd, John C.
    Flynn, Joseph
    Penza, Sam
    Devine, Steven M.
    Blum, Kristie A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (05): : 278 - 285
  • [32] IRRADIATED TUMOR VOLUME INFLUENCES LOCAL CONTROL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH 1-3 BRAIN METASTASES TREATED BY RADIOSURGERY
    van der Weide, H. L.
    de Kunder, S. L.
    Houben, R. M. A.
    Bosmans, G.
    Lambin, P.
    Baumert, B. G.
    NEURO-ONCOLOGY, 2010, 12 : 58 - 58
  • [33] Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Nakagawa, Hidetoshi
    Toyama, Tadashi
    Arai, Kuniaki
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    HEPATOLOGY RESEARCH, 2016, 46 (07) : 650 - 656
  • [34] Imaging progression-free survival: How much does it matter to patients?
    O'Donnell, Jennifer
    Robinson, Andrew George
    Booth, Christopher M.
    Koven, Rachel
    Eisenhauer, Elizabeth A.
    Brundage, Michael Donald
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [35] Potential prognostic factors in progression-free survival for patients with cervical cancer
    Hui-Hui Chen
    Wei-Yu Meng
    Run-Ze Li
    Qing-Yi Wang
    Yu-Wei Wang
    Hu-Dan Pan
    Pei-Yu Yan
    Qi-Biao Wu
    Liang Liu
    Xiao-Jun Yao
    Min Kang
    Elaine Lai-Han Leung
    BMC Cancer, 21
  • [36] Primary hypertension to predict progression-free survival of target therapy in patients with metastatic renal cell carcinoma
    Chi, Zhi Hong
    Mao, Li Li
    Si, Lu
    Cui, Chuan Liang
    Sheng, Xi Nan
    Li, Si Ming
    Tang, Bi Xia
    Guo, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] T-antigen as a biomarker of progression-free survival in patients with glioblastoma
    Guan, Liao
    Wang, Wenwen
    Ji, Xuefei
    Cheng, Hongwei
    Du, Weidong
    Ye, Lei
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (07): : 1765 - 1774
  • [38] The value of progression-free survival to patients with advanced-stage cancer
    Lesley J. Fallowfield
    Anne Fleissig
    Nature Reviews Clinical Oncology, 2012, 9 : 41 - 47
  • [39] The value of progression-free survival to patients with advanced-stage cancer
    Fallowfield, Lesley J.
    Fleissig, Anne
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (01) : 41 - 47
  • [40] Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients
    Hogdall, Estrid
    Fung, Eric T.
    Christensen, Ib Jarle
    Yip, Christine
    Nedergaard, Lotte
    Engelholm, Svend Aage
    Risum, Signe
    Petri, Anette Lykke
    Lundvall, Lene
    Lomas, Lee
    Hogdall, Claus
    PROTEOMICS CLINICAL APPLICATIONS, 2010, 4 (12) : 940 - 952
12345